Association of the P64k dihydrolipoamide dehydrogenase to the Neisseria meningitidis membrane

Biotecnologia Aplicada

Volumn 21, Issue 3, 2004, Pages 137-142

  Álvarez, Anabel ^a   Martín, Alejandro ^a   Falcón, Viviana ^a   De La Rosa, Maria C ^a   González, Sonia ^a   Guillén, Gerardo ^a   Silva, Ricardo ^a  

^a CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Cuba)

Author keywords

Dihydrolipoamide dehydrogenase; LpdA gene; Neisseria meningitidis; P64k protein; Prote n carrier

Indexed keywords

EID: 67650208321     PISSN: 08644551     EISSN: 10272852     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. S Harmych, R Arnette, R Komuniecki. Role of dihydrolipoyl dehydrogenase (E3) and a novel E3-binding protein in the NADH sensitivity of the pyruvate dehydrogenase complex from anaerobic mitochondria of the parasitic nematode, Ascaris suum. Mol Biochem Parasitol 2002; 125(1-2):135-46.
2. Berg A, Kok A. 2-Oxo acid dehydrogenase multienzyme complexes. The central role of the lipoyl domain. Biol Chem 1997;378:617-34.
3. Wei W, Li H, Nemeria N, Jordan F. Expression and purification of the dihydrolipoamide acetyltransferase and dihydrolipoamide dehydrogenase subunits of the Escherichia coli pyruvate dehydrogenase multienzyme complex: a mass spectrometric assay for reductive acetylation of dihydrolipoamide acetyl-transferase. Protein Expr Purif 2003:140-50.
4. Veenman CL, Lehmann J, Stohr T, Totterdell S, Yee B, Mura A, Feldon J. Comparisons of the densities of NADPHd reactive and nNOS immunopositive neurons in the hippocampus of three age groups of young nonhandled and handled rats. Brain Res Dev Brain Res, 1999;114(2):229-43.
5. Freudenberg W, Mayer F, Andreesen JR. Immunocytochemical localization of proteins P1, P2, P3 of glycine decarboxylase and of the selenoprotein PA of glycine reductase, all involved in anaerobic glycine metabolism of Eubacterium acidaminophilum. Arch Microbiol 1989;152:182-8.
6. Molle V, Girard-Blanc C, Kremer L, Doublet P, Cozzone AJ. Prost Protein PknE, a novel transmembrane eukaryotic-like serine/threonine kinase from Mycobacterium tuberculosis. Biochem Biophys Res Commun, 2003;308(4):820-5.
7. Silvestro L, Weiser JN, Axelsen PH. Antibacterial and antimembrane activities of cecropin A in Escherichia coli. Antimi-crob Agents Chemother, 2000; 44(3):602-7.
8. Argyrou A, Blanchard JL, Palfey BA. The lipoamide dehydrogenase from Mycobacterium tuberculosis permits the direct observation of flavin intermediates in catalysis. Biochemistry, 2002; 41(49):14580-90.
9. Bringas R, Fernandez J. A lipoamide dehydrogenase from Neisseria meningitidis has a lipoyl domain. Proteins 1995;21(4): 303-6.
10. Guillén G, Alvarez A, Silva R, Morera V, González S, Musacchio A, Besada V, Coizeau E, Caballero E, Nazábal C, Carmenate T, González LJ, Estrada R, Tambara Y, Padrón G, Herrera L. Expression in Escherichia coli of the lpdA gene, protein sequence analysis and immunological characterization of the P64K protein from Neisseria meningitidis. Biotechonol. Appl Biochem 1998;27:189-96.
11. Li de la Sierra I, Pernot L, Prangé T, Saludjian P, Schiltz M, Fourme R, Padrón G. Molecular Structure of the lipoamide Dehydrogenase Domain of a Surface Antigen from Neisseria meningitidis. J Mol Biol 1997;269:129-41.
12. Silva R, Selman M, Guillén G, Herrera L, Fernández JR, Novoa LI, Morales J, Morera V, González S, Tamargo B, del Valle J, Caballero E, Alvarez A, Coizeau E, Cruz S, Mussachio A. Nucleotide sequence coding for an outer membrane protein from Neisseria meningitidis and use of said protein in vaccine preparation. Eur Pat Appl 0 474 313 A2. (1994) USPat 5 286 484.
13. Carmenate T, Canaán L, Álvarez A, Delgado M, González S, Menéndez T, Rodés L, Guillén G. Effect of conjugation methodology on the immunogenicity and protective efficacy of meningococcal group C polysaccharide-P64k protein conjugates. FEMS Immunol Med Microbiol, 2004;40(3):193-9.
14. González S, Álvarez A, Caballero E, Vina L, Guillén G, Silva R. P64k meningococcal protein as immunological carrier for weak immunogens. Scand J Immunol 2000;52(2):113-6.
15. Bullock WO, Fernández JM, Short JM. XL-1Blue: A high efficiency plasmid transforming recA Escherichia coli K12 strain with beta-galactosidase selection. Biotechniques 1987;5(4):376-8.
16. Lewis RA, Bignell CR, Zeng W, Jones AC, Thomas CM. Chromosome loss from par mutants of Pseudomonas putida depends on growth medium and phase of growth. Microbiology, 2002;148:537-48.
17. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, New York, USA. 1989.
18. Dueñas S, Pajón R, Delgado M, Nogueiras E, Martín A. Electroporation of Neisseria meningitidis with plasmid DNA. Biotecnología Aplicada 1998;15(4): 247-9.
19. Sanger F, Niclen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci, USA 1977;74: 5463-67.
20. Taylor LA, Rose RE. A correction in the nucleotide sequence of the Tn903 kanamycin resistance determinant in pUC4K. Nucleic Acids Res 1988;16:358.
21. Henikoff S. Unidirectional digestion with exonuclease III creates targeted breakpoints for DNA sequencing. Gene 1984;28(3): 351-9.
22. Menéndez T, Alonso LM, Pérez M, Pajón R, Silva R. Influence of the length of the P64k protein N-terminus stabilizing peptide on the expression in Escherichia coli of the fused TbpB from Neisseria meningitids. Biotecnología Aplicada 1998;15:254-7.
23. Guillén G, Leal MJ, Alvarez A, Delgado M, Silva R, Herrera L. Cloning and expression of the Neisseria meningitidis 5C outer membrane protein. Acta Biotecnológica 1995;10:97-106.
24. Duarte CA, Guillén GE, Álvarez A, Carpio EL, Quintana D, Gómez C, Silva R, Nazábal C, Leal MJ, Martín AM. System for the expression of heterologous antigens as fusion proteins. WO 97/26359, 1997.
25. Spurr AR. A low viscosity epoxy resinembedding medium for electron microscopy. J Ultrastructure Research 1969;26: 31-43.
26. Frasch CE, Zollinger WD, Poolman JT. Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes. Reviews of Infectious Diseases 1985;7(4):504-10.
27. Matsumoto M, Funami K, Tanabe M, Oshiumi H, Shingai M, Seto Y, Yamamoto A, Seya T. Subcellular localization of Toll-like receptor 3 in human dendritic cells. J Immunol, 2003;171(6):3154-62.
28. Ala'Aldeen DAA, Westphal AH, DeKok A, Weston V, Atta MS, Baldwin TJ, Bartley J, Borriello SP. Cloning, sequencing, characterization and implications for vaccine design of the novel dihydrolipoyl acetyltransferase of Neisseria meningitidis. J Med Microbiol 1996;45(6):419-32.
29. lmros T, Burman LG, Bloom GD. Autolysis of Neisseria gonorrhoeae. J Bacteriol 1976;126(2):969-76.
30. Reshilov LN, Borovkova VM, Salov VF, Basnakian IA, Lopyrev IV. Formation of microvesicles in meningococcal cells during batch cultivation. Zh Mikrobiol Epidemiol Immunobiol, 1986;9:12-6. Russian.
31. Hiromasa Y, Fujisawa T, Aso Y, Roche TE. Organization of the cores of the mammalian pyruvate dehydrogenase complex formed by E2 and E2 plus the E3-binding protein and their capacities to bind the E1 and E3 components. J Biol Chem, 2004; 279(8):6921-33.
32. Hong YS, Korman SH, Lee J, Ghoshal P, Wu Q, Barash V, Kang S, Oh S, Kwon M, Gutman A, Rachmel A, Patel MS. Identification of a common mutation (Gly194Cys) in both Arab Moslem and Ashkenazi Jewish patients with dihydrolipoamide dehydrogenase (E3) deficiency: possible beneficial effect of vitamin therapy. J Inherit Metab Dis 2003;26(8):816-8.
33. Grafakou O, Oexle K, van den Heuvel L, Smeets R, Trijbels F, Goebel HH, Bosshard N, Superti-Furga A, Steinmann B, Smeitink J. Leigh syndrome due to compound heterozygosity of dihydrolipoamide dehydrogenase gene mutations. Description of the first E3 splices site mutation. Eur J Pediatr, 2003;162(10):714-8.
34. Hemilä H. Lipoamide dihydrogenase of Staphylococcus aureus: nucleotide sequence and sequence analysis. Biochimica et Biophysica Acta 1991:119-23.
35. Maas E, Bisswanger H. Localization of the α-oxoacid dehydrogenase multienzyme complexes within the mitochondrion. FEBS Letters 277/1-2 (1990): 189-90.
36. Gutierrez-Correa J, Krauth-Siegel RL, Stoppani OA. Inactivation of Trypanosoma cruzi dihydrolipoamide dehydrogenase by leukocyte myeloperoxidase systems: role of hypochloride and nitrite related radicals. Rev Argent Microbiol. 2000 ;32(3):136-43.
37. Ben-Yedidia T, Arnon R. Design of peptide and polypeptide vaccines. Curr Op Biotech 1997;8:442-8.
38. Fattom A, Cho YH, Chu C, Fuller S, Fries L, Naso R. Epitope overload at the site of injection may result in suppression of the immune response to combined capsular polysaccharide conjugate vaccines. Vaccine 1999; 17:126-33.
39. Herzenberg LA, Tokuhisa T, Her-zenberg LA. Carrier-priming leads to hapten/specific suppression. Nature 1980;285:664-7.
40. Pérez A, Dickinson F, Cinza Z, Ruíz A, Serrano T, Sosa J, González S, Gutiérrez Y, Nazábal C, Gutiérrez O, Guzmán D, Díaz M, Delgado M, Caballero E, Sardiñas G, Alvarez A, Martín A,Guillén G, Silva R. Safety and preliminary immunogenicity of the recombinant outer membrane protein P64k of Neisseria meningitidis in human volunteers. Biotechnology and Applied Biochemistry 2001;34:121-5.